Rights and permissions
About this article
Cite this article
PEG IFN-α-2a + ribavirin for hepatitis C: less impact on QOL. Inpharma Wkly. 1434, 6 (2004). https://doi.org/10.2165/00128413-200414340-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414340-00016